PharmaAudit Services
Site, TMF and Database Audit
Inspection Preparation
CRO Evaluation
SOP Development
GCP Testing & Training
GCP Training
GCP Knowledge Testing
Free GCP Games
Case Studies
Mock Inspection
TMF Audit
Administration
Home Page
Contact Us
GCP Tests

Answer the questions below and then click the button. The next page will mark your answers and show you how well you have done compared with the previous people who have taken the tests.

Test: ICH GCP Informed Consent Section

Question Number 1:

According to the section on Informed Consent of Trial Subjects in ICH GCP the language used in the oral and written information about the trial , including the written informed consent, should be as XXXXX as practical.

What is the XXXXX?

A
Simple
B
Straightforward
C
Non-technical
D
Easy to understand

Question Number 2:

According to the section on Informed Consent in ICH GCP, prior to a subjects participation in a trial the written informed consent form should be XXXX by the subject or the subjects legally acceptable representative.

What is the XXXX?

A
Read
B
Signed
C
Signed and dated
D
Signed and personally dated

Question Number 3:

According to the Informed Consent Section of ICH GCP, when a clinical trial includes subjects who can only be enrolled in the trial with the consent of the subjects legally acceptable reprsentative, what is stated about the involvement of the subject in the informed consent process.

A
They are not included
B
The subject should be informed
C
The subject should be informed to the extent compatible with the subjects understanding
D
The subject should be informed to the extent compatible with the subjects understanding and if capable sign and personally date the written informed consent

Question Number 4:

Which of the following is not listed as one of the subjects that written informed consent should include explanations of?

A
The foreseeable circumstances and/or reasons under which the subjects participation in the trial may be terminated
B
The reasonably foreseeable risksor inconveniences to the subject and when applicable to an embryo, fetus, or nursing infant
C
The alternative procedure or courses of treatment that may be available to the subject and their important potential benefits and risks
D
The qualifications of the investigator and if applicable a statement of any non-trial related payments made by, either directly or indirectly, the sponsor to the investigator.

Question Number 5:

According to ICH GCP the informed consent discussion and written informed consent form should include what information about what is available to the subject in the event of a trial-related injury?

A
Nothing
B
Compensation
C
Treatment
D
Compensation and Treatment

 

(c) PharmaAudit 2009
All rights reserved
PharmaAudit
Home Page
Contact Us